Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 61-80 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 61 | Isar Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Isar Aerospace has the clearest recent opportunity setup in this screen: a June 2026 article summary says it raised €270 million ($312 million), has total capital near €1 billion excluding ESA support, and scheduled a Spectrum launch window for June 15-21 from Norway. If execution succeeds, the article frames it as a milestone for European commercial launch capability. Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date. Evidence
Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation. |
| 62 | K2 Space mediummedium | Opp 5 Risk 2 | Thesis: K2 Space has a credible 1 year+ opportunity setup because a dated June 11, 2026 article says it landed a key supplier role in the U.S. Space Force's next-generation military communications network and will provide the satellite platform for SES's PTS-G program, which could support longer-cycle strategic relevance and follow-on demand if execution proceeds. Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones. Evidence
Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation. |
| 63 | Millennium Space Systems mediummedium | Opp 5 Risk 4 | Thesis: Millennium Space Systems has a positive long-horizon signal from being named among companies awarded Space Force Andromeda contracts tied to geosynchronous reconnaissance and surveillance satellites, indicating program access in a strategically relevant segment. Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work Evidence
Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation. |
| 64 | Northwood Space mediumweak | Opp 5 Risk 2 | Thesis: Northwood Space has the clearest reviewed sources-supported opportunity among the smaller private names because the reviewed sources directly says it has a Space Force contract and a factory tied to optical ground stations, which supports durable government-linked space infrastructure relevance over a 1 year+ horizon. Why now: The reviewed sources' membership rationale explicitly anchors current relevance to a Space Force contract and factory buildout tied to optical ground stations, citing article, though the article is not supplied in the reviewed sources. Caveats: No representative article object or is included despite the cited article ID. Single-article support limits conviction. |
| 65 | Orion Space Solutions mediummedium | Opp 5 Risk 2 | Thesis: Orion Space Solutions has meaningful contract-backed business activity within the recent evidence window, with initial contracts over $24 million, over 25 payloads, multi-year execution scope, and total potential value above $100 million if batch deliveries complete. Why now: A representative article dated March 29, 2026 states Orion Space Solutions won initial contracts worth over $24 million to build more than 25 advanced payloads, with total potential value over $100 million and multi-year design, manufacturing, testing, and calibration work, which can matter over a 1 year+ horizon Evidence
Caveats: This is supporting article context and explicitly weaker than direct structured company-event evidence. The customer is undisclosed. Only one article is retained; same-article repetition is not independent confirmation. |
| 66 | OroraTech mediummedium | Opp 5 Risk 2 | Thesis: OroraTech shows moderate long-horizon opportunity because a dated May 4, 2026 article reports deployment of four proprietary wildfire-detection satellites for Greece as part of an operational sovereign system, suggesting real product deployment, country-level adoption, and vertically integrated execution from satellites through data processing. Why now: A dated article with May 4, 2026 states that four satellites in the Hellenic Fire System launched and deployed on May 3, making Greece the first country with a sovereign operational wildfire-detection constellation; for a 1 year+ horizon, that kind of operational deployment can matter as a proof point for follow-on adoption if it persists Evidence
Caveats: The available evidence is weak context/supporting article context, not stronger company-specific events. Same article supplies the key claims, so this is not independent confirmation. No material adverse evidence is available, but absence of risk evidence is not proof of low risk. |
| 67 | RapidTek lowweak | Opp 5 Risk 3 | Thesis: Relatively better opportunity within these reviewed sources: the membership rationale says RapidTek successfully connected its Black Kite-2 8U CubeSat with ground stations and aims for a LEO IoT network. That is a concrete technical milestone with a plausible 1 year+ commercialization pathway if network development continues. Why now: Why now is the reported successful satellite-ground connection and stated LEO IoT ambition referenced in article ID, though the reviewed sources does not include the article or exact timing details. Caveats: The technical milestone is described only in membership rationale, not available direct evidence. Article ID has no in the reviewed sources. Technical connectivity milestone is weaker than contracted commercial deployment. |
| 68 | Skyroot Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Skyroot has a credible long-horizon opportunity case from recent financing and launcher milestone positioning: Fortune India says it raised nearly $60 million at a $1.1 billion pre-money valuation and is preparing for the maiden flight of Vikram-1, its orbital launch vehicle. Why now: The relevant dated development is the reported financing on May 7, 2026 alongside the stated approach to the Vikram-1 maiden flight, which fits a 1 year+ thesis if execution progresses. Evidence
Caveats: Support is supporting article context only; the reviewed sources have no direct positive events available for Skyroot. Same-article repeated context rows are not independent confirmation. |
| 69 | Spark Space mediummedium | Opp 5 Risk 5 | Thesis: Spark Space has a credible speculative opportunity because supporting article context says it tested an engine and raised funds for an electric-pump rocket, which are relevant proof points for an early launch company over a 1 year+ horizon. Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously. Evidence
Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation. |
| 70 | Stellar Alpina AG lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources' membership rationale states Stellar Alpina is a Swiss space startup that raised CHF 3.5M pre-seed and is developing rotating detonation rocket engines for in-space mobility. For a 1 year+ horizon, recent financing plus differentiated propulsion development creates meaningful upside optionality. Why now: Why now is relatively better than peers because the rationale includes a recent capital raise and a specific product focus, both of which can influence a 1 year+ strategic trajectory, though no direct dated evidence are available to verify recency sequencing. Caveats: Membership rationale cites article IDs: and: but no are present. The reviewed sources contain no direct positive or negative evidence arrays despite the financing statement in the rationale. Early-stage propulsion development is inherently high-uncertainty, but that is inferred from stage and product type, not from a available adverse article. |
| 71 | The Exploration Company lowweak | Opp 5 Risk 2 | Thesis: Moderate long-horizon opportunity based on article-context evidence that the company won an ESA cargo return service contract and was ranked first in the competition, which suggests external validation and potential programmatic traction if still current. Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious. Evidence
Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence. |
| 72 | Tomorrow.io lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale states Tomorrow.io raised an additional $35M, bringing its Series F to $210M, for the DeepSky AI-native satellite constellation, which supports a moderate long-horizon opportunity thesis around financing-backed constellation buildout and commercialization. Why now: The 'why now' is the capital raise described in the reviewed sources' membership rationale via article: but the ranking payload does not include the article or a richer reviewed evidence row, so recency and detail are only partially grounded. Evidence
Caveats: The reviewed sources does not provide the article for the cited membership-support article. This is mainly a financing-backed opportunity thesis, not a contract- or revenue-backed one in these reviewed sources. |
| 73 | Transcelestial lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale describes Transcelestial as a private lasercom startup aiming for a LEO constellation and having a partnership to advance optical communications architecture in LEO. If current, that supports a durable 1 year+ opportunity tied to optical communications buildout. Why now: Why now is only moderate because the membership rationale references support references including, and: but the reviewed sources does not provide or article summaries for them. Without visible dated article detail, the near-current business state cannot be confirmed. Caveats: Important claims appear only in the membership rationale; no -bearing direct evidence is exposed. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 74 | Umbra mediummedium | Opp 5 Risk 2 | Thesis: Umbra has a moderate long-horizon opportunity case because a dated June 22, 2026 article describes it as a U.S. commercial space company developing and operating a SAR satellite constellation that delivers rapid, regular, high-resolution data to public and private customers, suggesting an already-operational capability base that could support durable growth over a 1 year+ horizon. Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong. Evidence
Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring. |
| 75 | Unastella lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources say Unastella is a South Korean startup developing small satellite launch vehicles, has raised a Series B, and successfully launched Una Express-I. That combination of financing and a successful launch milestone is one of the clearer long-horizon opportunity setups in this screen, if current. Why now: Why now is relatively stronger because the rationale includes both funding and a technical milestone, which are durable indicators for a 1 year+ horizon, though exact dates and chronology cannot be checked from the reviewed sources' empty post-recent evidence window evidence tables. Caveats: Membership rationale cites article IDs: and: but no are given. No direct events or summaries are available after recent evidence window, so success claims cannot be quoted from the reviewed sources. Opportunity and risk both reflect a capital-intensive launch model with limited reviewed sources verification. |
| 76 | Univity lowweak | Opp 5 Risk 4 | Thesis: Best-supported opportunity in this sparse batch: the reviewed sources membership rationale says Univity raised $32M to build a European satellite network rivaling Starlink, which is a direct financing-and-buildout claim that can matter over a 1 year+ horizon if execution continues. Why now: Why now is the claimed funding event and network build plan referenced in article ID: but the reviewed sources does not provide the article or detailed timestamp, so recency is only partially grounded. Caveats: The key claim comes from membership rationale rather than available direct evidence. Article ID: is referenced without a. No evidence of downstream execution, contracts, launches, or adoption is present. |
| 77 | Vantor lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale describes potentially material traction: Vantor is described as having won a $70M NGA GEOINT platform contract, additional NGA Luno B contracts for orbital intelligence and AI change detection, and plans satellite constellation expansion, which would support a multi-quarter opportunity thesis if confirmed in article detail. Why now: Why now is only moderate because the membership rationale references significant contracts via support references including: but the reviewed sources provide no or representative article detail for citation-quality corroboration. The forecast horizon of 1 year+ could fit contract conversion and constellation expansion if current, but recency cannot be validated from visible article rows. Caveats: The contract and expansion claims appear only in membership rationale text; no representative article with is included. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 78 | Albedo lowweak | Opp 4 Risk 4 | Thesis: Albedo has the clearest dated recency in the reviewed sources: an external article states the company announced plans on April 9 to send its second spacecraft and is preparing a second VLEO mission for 2027 launch, which suggests continued program progression over a 1 year+ horizon Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission Evidence
Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 79 | Apogeo Space lowweak | Opp 4 Risk 2 | Thesis: Apogeo Space has moderate long-horizon opportunity on reviewed sources evidence because it is described as having a ground-station integration agreement and technical collaboration on CubeSat platforms, payloads, and joint missions, indicating active ecosystem positioning in space infrastructure and services. Why now: The reviewed sources' membership rationale cites article: for the integration agreement and technical collaboration, but no article or direct evidence are included. Caveats: Evidence is thin and article-level details are missing. Collaboration and integration agreements are weaker than revenue-bearing customer wins. Single-article support limits conviction. |
| 80 | Astranis lowmedium | Opp 4 Risk 2 | Thesis: Astranis has recent supporting article context indicating both contract relevance and financing support: it was included among companies awarded Space Force Andromeda contracts on April 8, 2026 and was reported to have raised a $300 million Series E on June 19, 2026, which supports a longer-horizon capacity and program participation thesis. Why now: Recent dated context within the 90-day recent evidence window points to fresh financing and government program inclusion, both relevant for a 1 year+ horizon: Andromeda context on April 8, 2026 and funding context on June 19, 2026 Evidence
Caveats: Evidence is mainly supporting article context, which is weaker than direct event/fact evidence. An older 2025 article about a 2027 transportation deal exists, but it is outside the recent evidence window and not used as current proof. |
Risk view
Showing rows 401-420 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 401 | ULA lowweak | Opp 1 Risk 1 | Thesis: There is no retained 90-day negative evidence to support a material risk case. Why now: Coverage data shows zero retained article IDs and evidence after the recent evidence filter, so there is no recent thesis-driving evidence in the reviewed sources. Caveats: Only membership-level context is present in the served reviewed sources. No direct event, fact, or article-context evidence remains within the recent evidence window. Direction cannot be inferred from category membership alone. |
| 402 | Uncovr lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available, but absence of negative evidence is not a positive thesis. Why now: The only described context is a funding-roundup article referenced in phase2 rationale, but no post-recent evidence window evidence or are provided for thesis use. Caveats: Phase2 rationale says Uncovr was listed as having raised $7M in article: but no was provided in the reviewed sources. Despite support_counts mentioning dated event/facts, the company-level available evidence arrays are empty and coverage data shows evidence after recent evidence window = 0. Broad funding roundup context is weaker than direct company-specific event evidence. |
| 403 | United Launch Alliance lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is provided in the reviewed sources after recent evidence filtering, so a negative thesis is not established either. Why now: Why now is unsupported because the reviewed sources contain no surviving article or evidence after the selected recent evidence window; business-state or catalyst timing cannot be judged from the provided materials. Caveats: Zero evidence survived after recent evidence filtering. Company membership in the cohort is not thesis attractiveness. No dated catalyst, performance update, or direct risk item is included. |
| 404 | Univity lowweak | Opp 1 Risk 1 | Thesis: A large planned constellation and early-stage buildout could imply execution risk, but the reviewed sources provide no direct adverse evidence within the available evidence set. Why now: No usable within the recent evidence window evidence were available after filtering; recency-based thesis formation is therefore not supported in these reviewed sources. Caveats: Coverage after recent evidence window is effectively empty in these reviewed sources. Membership rationale is not directional proof. |
| 405 | Vantor lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in the reviewed sources, so there is no evidence-based risk thesis at present. Why now: Why now is weak because the reviewed sources contain no retained post-cutoff directional evidence. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without and cannot be cited directly here. |
| 406 | Varda Space Industries lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources also contains no retained 90-day direct negative evidence, so there is not enough support for a material adverse thesis either. Why now: No within the recent evidence window company-specific evidence were available after filtering; articles after recent evidence window and evidence after recent evidence window are both zero in coverage data, so recency-based thesis formation is not supported in these reviewed sources. Caveats: 12 articles were considered historically, but zero article IDs remained after the 90-day recent evidence filter. Membership rationale cites older support article IDs but those underlying evidence are not retained in the served reviewed sources. Scores are constrained by evidence absence, not by a documented negative business development. |
| 407 | Veact lowweak | Opp 0 Risk 1 | Thesis: No material adverse thesis is supported either; the main issue is insufficient evidence rather than identified business deterioration. Why now: No why-now catalyst is supported because the reviewed sources contain no post-recent evidence window evidence. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. A broad funding roundup is not enough to establish thesis direction. Coverage data shows articles after recent evidence window = 0. |
| 408 | Venturi Astrolab lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in these reviewed sources. Why now: Why now is weak because despite 30 articles considered, coverage data shows articles after recent evidence window of 0 and evidence recent evidence review kept_rows of 0, so the reviewed sources does not preserve dated supporting evidence inside the 90-day window. Caveats: Phase-2 rationale cannot substitute for cited article evidence because are absent. No direct positive or negative evidence arrays are populated. Low scores are driven by evidence retention limits in these reviewed sources. |
| 409 | Virgin Galactic Holdings, Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct negative evidence inside the scoring fields, so no material adverse thesis is supportable here. Why now: The phase2 rationale references three article IDs, but the reviewed sources includes no representative article summaries or evidence to cite for a dated catalyst. Coverage data shows zero article IDs after recent evidence window and zero available evidence, so the current-state thesis is unsupported by reviewed sources detail. Caveats: Do not infer direction from company identity or sector relevance alone. Phase2 membership support cannot substitute for direct thesis evidence. |
| 410 | Volteum lowweak | Opp 0 Risk 1 | Thesis: No direct negative evidence is available; current ranking is constrained by missing evidence rather than identified downside events. Why now: No catalyst is supported in the reviewed sources due to zero post-recent evidence window evidence. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. Funding-roundup presence alone is not directional proof. Evidence strength remains minimal. |
| 411 | Vyoma GmbH lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is supplied after recent evidence filtering, so a risk thesis is not supported either. Why now: Why now is unsupported because the reviewed sources contain no surviving evidence after recent evidence filtering; timing and business-state changes cannot be validated from the provided material. Caveats: Zero evidence after recent evidence filtering. Membership rationale alone is not sufficient for directional scoring. No direct dated catalyst or adverse development is provided. |
| 412 | Windward lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is retained. The main risk is classification ambiguity and weak grounding, not a documented negative event. Why now: There is no validated within the recent evidence window catalyst. The only support cited is phase-2 rationale referencing, and without or retained evidence. Caveats: Reviewed evidence language distinguishes maritime domain awareness from space domain awareness. No retained article summaries or evidence are available after recent evidence window. Context-only relations must not be propagated into stronger thesis claims. |
| 413 | Windward Ltd. lowweak | Opp 1 Risk 1 | Thesis: There is no direct negative evidence. The only notable issue is that the available mention is relation context, which is insufficient for a real risk thesis. Why now: No catalyst is established. Coverage debug shows 27 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Relation context is explicitly weaker and not valid counterparty propagation evidence. |
| 414 | WISeKey International Holding Ltd lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources provide no retained within the recent evidence window direct negative evidence to support a risk thesis. Why now: There are zero available evidence after recent evidence window for ranking, so no evidence-backed timing signal is available. Caveats: Membership support mentions 21 LEO satellites launched and operational space-related infrastructure, but those claims are not accompanied here by retained ranking evidence or article. Without dated evidence inside the recent evidence window, score should remain low-conviction. |
| 415 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window negative evidence was available, so the reviewed sources does not support a material risk thesis. Why now: The reviewed sources have no retained dated evidence after the 90-day recent evidence window, so there is no citable timing edge for a 1 year+ ranking. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs and, but no or retained evidence text are provided here. Later-dated evidence could supersede older listing or contract-status claims, but no such retained evidence exists in these reviewed sources. |
| 416 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: There is no retained adverse evidence in the active recent evidence window, so only a minimal risk score is warranted. Why now: Although membership support cites articles, and: no representative summaries or retained evidence are included here, leaving no current catalyst basis. Caveats: 54 articles considered, but 0 retained after recent evidence filtering. Cannot elevate based on membership rationale alone. |
| 417 | Zaro lowweak | Opp 0 Risk 1 | Thesis: No reviewed sources-supported negative thesis is available either; the issue is missing evidence rather than documented adverse developments. Why now: There is no current or durable catalyst supported by the reviewed sources because no evidence survived into the available post-recent evidence window set. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. General funding-roundup context is weaker than direct event or fact evidence. Coverage remains insufficient for a directional call. |
| 418 | Zoove Space lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is supplied. Main risk is that accelerator participation alone is weak support for a durable commercial thesis. Why now: The reviewed sources offers no in-window evidence to confirm timing beyond the phase-2 rationale, so the current catalyst strength is limited. Caveats: No evidence remained after the 90-day recent evidence window. Accelerator selection is a weak signal relative to financing, contracts, or operating milestones. No direct dated article is available in the reviewed sources body. |
| 419 | Akashalabdhi lowweak | Opp 0 Risk 0 | Thesis: No negative thesis is supportable because the reviewed sources contain no direct negative evidence for Akashalabdhi within the recent evidence window. Why now: There is no visible near-term or long-horizon company-specific catalyst in the reviewed sources. The membership review explicitly says the only included article does not mention Akashalabdhi in the visible summary, and coverage debug shows zero articles and zero evidence after recent evidence window. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article. Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. The reviewed sources itself says visible evidence is insufficient to determine even qualifying membership. |
| 420 | Amentum Holdings Inc. lowweak | Opp 0 Risk 0 | Thesis: No negative thesis is supportable from retained reviewed sources evidence because there are no direct negative evidence and no articles retained after the 90-day recent evidence window. Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite large historical mention volume. Caveats: Phase-2 rationale references article IDs and, but no article summaries or retained evidence are included here. Historical aerospace exposure does not create a current directional thesis without retained evidence. |